Summary
Baker Hughes Company (BKR) has announced a change in its Board of Directors, with a director departing and a new director being appointed. Lynn L. Elsenhans will not seek re-election at the upcoming 2025 Annual Meeting of Shareholders after a tenure that began in 2019. Her departure is amicable and not due to any disagreements with the Company. Concurrently, the Board has elected Ilham Kadri to join the Board, effective May 1, 2025, expanding the Board's size from ten to eleven members. Dr. Kadri brings extensive global leadership experience, most recently as CEO of Syensqo S.A. and previously as CEO of Solvay S.A. Her appointment is expected to enhance the Board's expertise, particularly given her recognized independence and qualification as an audit committee financial expert. She will serve on the Audit and Human Capital and Compensation Committees, with her compensation aligning with existing non-employee director compensation.
Key Highlights
- 1Lynn L. Elsenhans, a long-standing director since 2019 and chair of the Governance & Corporate Responsibility Committee, will not stand for re-election at the 2025 Annual Meeting.
- 2Ms. Elsenhans' decision to depart is not a result of any disagreement with Baker Hughes.
- 3Ilham Kadri has been elected to the Board of Directors, with her term commencing on May 1, 2025.
- 4The Board will expand from ten to eleven members, effective May 1, 2025, to accommodate the new director.
- 5Dr. Kadri possesses significant international leadership experience, including her current role as CEO of Syensqo S.A. and prior leadership at Solvay S.A.
- 6Dr. Kadri has been deemed independent and qualifies as an audit committee financial expert.
- 7Dr. Kadri will join the Audit and Human Capital and Compensation Committees.